Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lai

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|September 17, 2009
Identification of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride (AC220), a uniquely potent, selective, and efficacious FMS-like tyrosine kinase-3 (FLT3) inhibitorQi Chao, Kelly G Sprankle, Robert M Grotzfeld, et al.
Nature|September 18, 2024
Advanced CMOS manufacturing of superconducting qubits on 300 mm wafersJ Van Damme, S Massar, R Acharya, et al.
Life Science Alliance|March 29, 2019
A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesisPeter Ac Wing, Tamara Davenne, Jochen Wettengel, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Arylcarboxyamino-substituted diaryl ureas as potent and selective FLT3 inhibitorsHitesh K Patel, Robert M Grotzfeld, Andiliy G Lai, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 3, 2015
Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement, X Guan, L He, et al.
The Lancet. Diabetes & Endocrinology|September 5, 2021
Identifying adults at high-risk for change in weight and BMI in England: a longitudinal, large-scale, population-based cohort study using electronic health recordsMichail Katsoulis, Alvina G Lai, Karla Diaz-Ordaz, et al.
The Lancet. Digital Health|June 11, 2022
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health recordsJohan H Thygesen, Christopher Tomlinson, Sam Hollings, et al.
Journal of the Royal Society of Medicine|November 14, 2022
Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19-a data-driven retrospective cohort studyMehrdad A Mizani, Ashkan Dashtban, Laura Pasea, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Johnny Y Nagasawa, Karensa L Douglas, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2011
4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitorsMark W Holladay, Brian T Campbell, Martin W Rowbottom, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|September 17, 2009
Identification of N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride (AC220), a uniquely potent, selective, and efficacious FMS-like tyrosine kinase-3 (FLT3) inhibitorQi Chao, Kelly G Sprankle, Robert M Grotzfeld, et al.
Nature|September 18, 2024
Advanced CMOS manufacturing of superconducting qubits on 300 mm wafersJ Van Damme, S Massar, R Acharya, et al.
Life Science Alliance|March 29, 2019
A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesisPeter Ac Wing, Tamara Davenne, Jochen Wettengel, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2009
Arylcarboxyamino-substituted diaryl ureas as potent and selective FLT3 inhibitorsHitesh K Patel, Robert M Grotzfeld, Andiliy G Lai, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 3, 2015
Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement, X Guan, L He, et al.
The Lancet. Diabetes & Endocrinology|September 5, 2021
Identifying adults at high-risk for change in weight and BMI in England: a longitudinal, large-scale, population-based cohort study using electronic health recordsMichail Katsoulis, Alvina G Lai, Karla Diaz-Ordaz, et al.
The Lancet. Digital Health|June 11, 2022
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health recordsJohan H Thygesen, Christopher Tomlinson, Sam Hollings, et al.
Journal of the Royal Society of Medicine|November 14, 2022
Using national electronic health records for pandemic preparedness: validation of a parsimonious model for predicting excess deaths among those with COVID-19-a data-driven retrospective cohort studyMehrdad A Mizani, Ashkan Dashtban, Laura Pasea, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2015
Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograftSteven P Govek, Johnny Y Nagasawa, Karensa L Douglas, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2011
4-Quinazolinyloxy-diaryl ureas as novel BRAFV600E inhibitorsMark W Holladay, Brian T Campbell, Martin W Rowbottom, et al.
Pageof 15